Pharmocann Global Ltd. Logo

Pharmocann Global Ltd.

Researches, cultivates, and produces medical-grade cannabis and hemp products.

PMCN-M | TA

Overview

Corporate Details

ISIN(s):
IL0010968902
LEI:
Country:
Israel
Address:
Horesh Haalonim 1, 3009500 Ramat Yishai

Description

Pharmocann Global Ltd. is a company specializing in the research, cultivation, production, and distribution of medical-grade cannabis products. Its product portfolio includes various formulations such as oils, ointments, tablets, and inhalers designed for medical applications. The company emphasizes a pharmaceutical approach, adhering to Good Manufacturing Practices (GMP) to create standardized and validated cannabis-based medicines. It operates its own cultivation facilities, including research and development greenhouses, and collaborates with research institutions to advance its product development. The company also produces and distributes hemp-based cosmetic and seed oil products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 19:38
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of Au…
English 99.3 KB
2025-02-17 18:43
Changes in the company's name and security, effective as of February 19, 2025
Hebrew (modern) 118.3 KB
2023-10-03 16:36
Excellence will cease to operate as a market maker in the company's shares as o…
Hebrew (modern) 118.8 KB
2020-08-23 11:39
Investors Presentation - August 2020
English 20.2 MB
2020-08-23 11:39
Investors Presentation - August 2020
Russian 42.3 KB

Automate Your Workflow. Get a real-time feed of all Pharmocann Global Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmocann Global Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmocann Global Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.